Aurobindo Pharma receives USFDA Approval for Bivalirudin Injection Aurobindo Pharma receives USFDA Approval for Bivalirudin Injection Shohini Nath / Monday, July 30, 2018 0 1560 Article rating: 5.0 Aurobindo Pharma has received the final approval from the US Food and Drug Administration for Bivalirudin Injection indicated for the use as an anticoagulant in patients. The product will be launched in September 2018. With respect to the news, the shares of Aurobindo soared 2 per cent. Read more
Ten stocks close to their 52-week high Ten stocks close to their 52-week high Shital Jibhe / Monday, July 30, 2018 0 1118 Article rating: 5.0 The markets on July 30, 2018 opened gap up. BSE Sensex is trading at 37,407.49, up by 70.64 points and the Nifty is trading at 11,290.45, up by 12.10 points. Read more
Wockhardt sets-up facility in Middle East, surges by 3.5 per cent Wockhardt sets-up facility in Middle East, surges by 3.5 per cent Apurva Joshi / Monday, July 30, 2018 0 1233 Article rating: 5.0 Wockhardt Limited has set-up its first facility in the Middle East for manufacturing of NCEs (New Chemical Entities). It will cater to the global markets through its Dubai arm of its subsidiary Wockhardt Bio AG. Read more
ICICI Bank jumps up on reporting stable asset quality in Q1FY19 ICICI Bank jumps up on reporting stable asset quality in Q1FY19 Rohan Takalkar / Monday, July 30, 2018 0 1383 Article rating: 5.0 ICICI Bank posted a net loss in Q1FY19 due to higher provisions in the quarter. However, the bank also witnessed an improvement in asset quality. Read more
Units of Morepen Labs receives approval for 2 API drugs Units of Morepen Labs receives approval for 2 API drugs Gayathri Udyawar / Monday, July 30, 2018 0 1073 Article rating: 5.0 The USFDA has accorded twin approvals to the company's bulk drug facilities in Baddi and Masulkhana, in Himachal Pradesh for export to the US market. The stock spiked up by more than 10 per cent on Monday. Read more